Css LLC Biogen Inc. Call Options Transaction History

Css LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $1.69 Million - $2.06 Million	-6,700 Reduced 28.39%	16,900 $4.68 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $4.59 Million - $6.34 Million	23,600 New	23,600 $6.3 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.97 Million - $2.34 Million	-10,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $7.15 Million - $9.01 Million	-36,900 Reduced 77.85%	10,500 $2.21 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $7.64 Million - $9.81 Million	34,100 Added 256.39%	47,400 $11.4 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $3.31 Million - $4.32 Million	-11,700 Reduced 46.8%	13,300 $3.76 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $20.6 Million - $33 Million	-79,500 Reduced 76.08%	25,000 $8.66 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $24.4 Million - $28.6 Million	-100,500 Reduced 49.02%	104,500 $29.2 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $37.2 Million - $55.9 Million	157,300 Added 329.77%	205,000 $50.2 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $12.4 Million - $14.3 Million	46,900 Added 5862.5%	47,700 $13.5 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $517,320 - $685,100	-2,000 Reduced 71.43%	800 $215,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $591,470 - $750,288	-2,200 Reduced 44.0%	2,800 $886,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $1.1 Million - $1.52 Million	5,000 New	5,000 $1.48 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.